SonoScape Medical Corp Net Asset Quality Index

Latest as of March 2026: 75.9%

SonoScape Medical Corp net asset quality index. SonoScape Medical Corp (300633) has a Net Asset Quality Index of 75.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.30 Billion minus total liabilities of CN¥1.04 Billion yields net assets of CN¥3.26 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check SonoScape Medical Corp (300633) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Quality Index

75.9%
Equity / Total Assets

Net Assets

CN¥3.26 Billion
CNY

Total Assets

CN¥4.30 Billion
CNY

Total Liabilities

CN¥1.04 Billion
CNY

Net Asset Quality Index of SonoScape Medical Corp (2012–2025)

Net asset quality index of SonoScape Medical Corp from 2012 to 2025. This chart shows how SonoScape Medical Corp's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 75.9%, representing net assets of CN¥3.26 Billion against total assets of CN¥4.30 Billion CNY. See SonoScape Medical Corp shareholders equity for net asset value and shareholders' equity analysis.

SonoScape Medical Corp Net Asset Quality Index by Year (2012–2025)

SonoScape Medical Corp net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for SonoScape Medical Corp from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300633 market cap overview.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 74.0% CN¥3.26 Billion CN¥4.41 Billion CN¥1.14 Billion ▲ +2.0 pp
2024 72.1% CN¥3.11 Billion CN¥4.31 Billion CN¥1.20 Billion ▼ -11.3 pp
2023 83.4% CN¥3.15 Billion CN¥3.77 Billion CN¥625.46 Million ▲ +6.1 pp
2022 77.3% CN¥2.74 Billion CN¥3.54 Billion CN¥804.41 Million ▼ -0.7 pp
2021 78.0% CN¥2.36 Billion CN¥3.02 Billion CN¥665.18 Million ▲ +18.3 pp
2020 59.7% CN¥1.34 Billion CN¥2.25 Billion CN¥906.93 Million ▲ +1.6 pp
2019 58.2% CN¥1.40 Billion CN¥2.41 Billion CN¥1.01 Billion ▼ -13.3 pp
2018 71.4% CN¥1.31 Billion CN¥1.84 Billion CN¥524.67 Million ▼ -7.9 pp
2017 79.3% CN¥1.06 Billion CN¥1.34 Billion CN¥275.93 Million ▲ +8.5 pp
2016 70.8% CN¥720.11 Million CN¥1.02 Billion CN¥296.44 Million ▲ +10.3 pp
2015 60.5% CN¥566.21 Million CN¥935.73 Million CN¥369.52 Million ▲ +8.7 pp
2014 51.8% CN¥444.81 Million CN¥858.30 Million CN¥413.48 Million ▼ -6.5 pp
2013 58.3% CN¥365.08 Million CN¥625.75 Million CN¥260.67 Million ▲ +1.7 pp
2012 56.6% CN¥351.82 Million CN¥621.41 Million CN¥269.59 Million —
pp = percentage points